Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Top U.S. SNRIs based on revenue 2013

This statistic displays the top nine serotonin-norepinephrine reuptake inhibitors (SNRIs) based on total U.S. revenue in 2013. In that year, Pristiq was among the leading SNRIs generating 570 million U.S. dollars in revenue in the United States. SNRIs are a type of antidepressant drug used to treat major depression disorder or other mood disorders. They can also be used for anxiety disorders, obsessive-compulsive disorder, and other related disorders.

Top SNRIs based on U.S. revenue in 2013

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2014

Region

United States

Survey time period

2013

Supplementary notes

*SNRI: Serotonin-norepinephrine reuptake inhibitor.
Not available.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.